IMTechCon 2017

October 4-6, 2017
Chandigarh, India

The meeting aimed to create better engagement with key industry & academic leaders and establish a platform where the challenges of Industry and how academic/research institutions can forge new R&D partnerships and alliances can be discussed. One of the event’s goal was to boost the discovery of new drugs and push towards healthcare innovation and the formation of new start-ups.

Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.

 

Session

Opportunities & Challenges in Anti-Microbial Drug Discovery

Date: Thursday, October 5, 2017

Innovative drugs for neglected patients
Graeme Bilbe, R&D Director, Drugs for Neglected Diseases initiative (DNDi), Switzerland

 

Panel Discussion

  • Sanjiv Navangul, Managing Director, Janssen, India
  • Yossef Av-Gay, Professor, Division of Infectious Diseases, University of British Columbia, Canada
  • Bakulesh Khamar, Executive Director, Cadila Pharmaceuticals, India
  • D Srinivasa Reddy, Senior Scientist,CSIR-National Chemical Laboratory, Pune, India
  • Suman Rijal, Director, DNDi Regional Office, India
  • RK Shandil, Director & Vice President FNDR, India
  • D Behera, Professor & Head, Dept of Pulmonary Medicine, PGIMER Chandigarh, India

 

More information: